After Brexit – practical implications for trade mark owners
Latest Insights
/Passle/6130aaa9400fb30e400b709a/MediaLibrary/Images/2024-05-14-12-57-49-590-66435fcdd0157bd4400b5187.png)
UPC: Patient interest defence in good health
In a recent UPC decision, the interest of patients was discussed as a possible defence to infringement in the sphere of medical imaging...
Read more
/Passle/6130aaa9400fb30e400b709a/SearchServiceImages/2026-11-05-16-22-00-460-6aecad28ae66f07c29ce00f3.jpg)
CAR T cell therapies: Review of EPO decisions
Adoptive T cell therapies, including chimeric antigen receptor (CAR) T cell therapies, T cell receptor (TCR) therapies, and tumour...
Read more
/Passle/6130aaa9400fb30e400b709a/SearchServiceImages/2026-11-05-16-49-02-767-6aecb37e1723aac1fdfcbcca.jpg)
Patenting Diagnostic Methods in the US
The patentability of diagnostic inventions has long been a source of frustration for innovators seeking protection in the United States....
Read more